Our Clinical Publications

Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer: First Reported Clinical Outcomes From the UK

Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summary of the Emerald- Pancreas phase 1/expansion study located at Oxford University Hospital, UK

Stereotactic Magnetic Resonance−Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity Outcomes

Phase 3 trial of SABR in localised prostate cancer (PACE B)